Basaloid lesions of oral squamous epithelial cells and their association with HPV infection and P16 expression

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1605-1612

  Friedrich, Reinhard E ^a   Sperber, Carmen ^a   Jäkel, Thorsten ^a   Röser, Kerstin ^a   Löning, Thomas ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ALBERTINEN KRANKENHAUS   (Germany)

Author keywords

Basaloid squamous cell carcinoma; High risk HPV types; Human papilloma virus; Oral cancer; Oral dysplasia; Oral papilloma

Indexed keywords

PROTEIN P16; VIRUS DNA;

BASALOID SQUAMOUS CELL CARCINOMA; CONFERENCE PAPER; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH LESION; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TREATMENT OUTCOME;

EID: 77954598123     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Wain SL, Kier R, Vollmer RT and Bossen EH: Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol 17: 1158-1166, 1986. (Pubitemid 17182899)
2. Ihrler S: Pathologische Grundlagen. Manual Tumorzentrum München. W. Zuckschwerdt Verlag, München, 2002.
3. Paulino AF, Singh B, Shah JP and Huvos AG: Basaloid squamous cell carcinoma of the head and neck. Laryngoscope 110: 1479-1182, 2000.
4. Cann CI, Fried MP and Rothman KJ: Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin North Am 18: 367-388, 1985. (Pubitemid 16247365)
5. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000. (Pubitemid 30365531)
6. Banks ER, Frierson HF, Mills SE, George E, Zarbo RJ and Swanson PE: Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 16: 939-946 1992.
7. Morice WG and Ferreiro JA: Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol 29: 609-612, 1998.
8. Jäkel KT and Löning T: Differential diagnosis of basaloid salivary gland tumors. Pathologe 25: 46-55, 2004 (in German). (Pubitemid 38235208)
9. Owonikoko T, Loberg C, Gabbert HE and Sarbia M: Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study. J Pathol 193: 155-161, 2001. (Pubitemid 32118125)
10. Coletta RD, Cotrim P, Vargas PA, Villalba H, Pires FR, de Moraes M and de Almeida OP: Basaloid squamous cell carcinoma of the oral cavity: report of 2 cases and study of Ag-NOR, PCNA, p53, and MMP expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91: 563-569, 2001. (Pubitemid 33601666)
11. Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ and Wal-boomers MJ: Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 33: 901-905, 1995.
12. Kappes S, Milde-Langosch K, Kressin P, Passlack B, Dockhorn-Dworniczak B, Röhlke P and Löning T: p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 64: 52-59, 1995.
13. Löning T, Meichsner M, Milde-Langosch K, Hinze H, Orlt I, Hörmann K, Sesterhenn K, Becker J and Reichart P: HPV DNA detection in tumours of the head and neck: a comparative light microscopy and DNA hybridization study. ORL J Otorhinolaryngol Relat Spec 49: 259-269, 1987. (Pubitemid 18011758)
14. Friedrich RE: Immunhistochemische und autoradiographische Untersuchungen zum ana-plastischen Karzinom der Kopf-Hals-Region. Dissertation, FU Berlin, 1993.
15. Poetsch M, Lorenz G, Bankau A and Kleist B: Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck 25: 904-910, 2003. (Pubitemid 37323005)
16. Coppola D, Catalano E, Tang CK, Elfenbein IB, Harwick R and Mohr R: Basaloid squamous cell carcinoma of floor of mouth. Cancer 72: 2299-305, 1993. (Pubitemid 23299590)
17. Campman SC, Gandour-Edwards RF and Sykes JM: Basaloid squamous carcinoma of the head and neck. Report of a case occuring in the anterior floor of the mouth. Arch Pathol Lab Med 118: 1229-1232, 1994.
18. Ide F, Shimoyama T, Horie N and Kusama K: Basaloid squamous cell carcinoma of the oral mucosa: a new case and review of 45 cases in the literature. Oral Oncology 38: 120-124, 2002. (Pubitemid 34076584)
19. Begum S and Westra WH: Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol 32: 1044-1050, 2008.
20. Luna MA, Naggar AE, Parichatikanond P, Weber RS and Batsakis JG: Basaloid squamous carcinoma of the upper aerodigestive tract. Cancer 66: 537-542, 1990.
21. El-Mofty SE: Human papillomavirus-related carcinomas of the upper aerodigestive tract. Head Neck Pathol 1: 181-185, 2007.
22. Miller CS and White DK: Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82: 57-68, 1996.
23. Zhang ZY, Sdek P, Cao J and Chen WT: Human papillomavirus type 16 and 18 DNA in oral squamous cell carcinoma and normal mucosa. Int J Oral Maxillofac Surg 33: 71-74, 2004. (Pubitemid 38035496)
24. Nemes JA, Deli L, Nemes Z and Marton IJ: Expression of p16INK4A, p53 and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 344-352, 2006.
25. Furniss CS, McClean MD, Smith JF, Bryan J, Nelson HH, Peters ES, Posner MR, Clark JR, Eisen EA and Kelsey KT: Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 120: 2386-2392, 2007.
26. Mishra A, Bharti AC, Varghese P, Saluja D and Das BC: Differential expression and activation of NF-κB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer 119: 2840-2850, 2006. (Pubitemid 44846236)
27. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH and Turek LP: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Nat Cancer Inst 96: 449-455, 2004. (Pubitemid 38443648)
28. Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, Shyr Y, Murphy BM, Cmelak AJ, Burkey BB, Netterville JL, Levy S, Yarbrough WG and Chung CH: Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12: 701-709, 2006. (Pubitemid 43259848)
29. Fregonesi P, Teresa DB, Duarte RA, Neto CB, de Oliveira M and Soares CP: p16 immun-histochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 51: 1291-1297, 2003. (Pubitemid 37187581)
30. De Oliveira DE, Bacchi MM, Macarenco RS, Tagliarini JV, Cordeiro RC and Bacchi CE: Human papillomavirus and Epstein-Barr virus infection, p53 expression, and cellular proliferation in laryngeal carcinoma. Am J Clin Pathol 126: 284-293, 2006.
31. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA and Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31: 259-266, 2006. (Pubitemid 44141088)
32. Hammarstedt L, Lingquist D, Dahlstrand H, Romanitan M, Onelöv L, Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T and Munck-Wikland E: Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119: 2620-2623, 2006.
33. Henley JD, Summerlin DJ and Tomich CE: Condyloma accuminatum and condyloma-like lesions of the oral cavity: a study of 11 cases with an intraductal component. Histopathology 44: 216-221, 2004.
34. Kansky AA, Seme K, Maver PJ, Luzar B, Gale N and Poljak M: Human papillomaviruses (HPV) in tissue specimens of oral squamous cell papillomas and normal oral mucosa. Anticancer Res 26: 3197-201, 2006. (Pubitemid 44161823)
35. Lopez Amado M, Castro Lareo I, Lozano Ramirez A and Caballero Torcuato L: Epidemiology of otolaryngological squamous cell papillomas in a Spanish subpopulation during a twenty-year period. Rev Laryngol Otol Rhinol 117: 105-110, 1996. (Pubitemid 26266529)
36. Lu DW, El-Mofty SK and Wang HL: Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod Pathol 16: 692-699, 2003.
37. Salcedo M, Taja L, Utrera D, Chávez P, Hidalgo A, Pérez C, Benítez L, Castañeda C, Delgado R and Gariglio P: Changes in retinoblastoma gene expression during cervical cancer progression. Int J Exp Pathol 83: 275-286, 2002.
38. Koyamatsu Y, Yokoyama M, Nakao Y, Fukuda K, Saito T, Matsukuma K and Iwasaka T: A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol 90: 547-51, 2003.
39. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, Dallenbach-Hellweg G, Schmidt D and von Knebel Doeberitz M: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284, 2001. (Pubitemid 32225381)
40. KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 439: 55-61, 2001.
41. INK4A are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25: 884-891, 2001.
42. Sano T, Oyama T, Kashiwabara K, Fukuda T and Nakayima T: Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741-1748, 1998.
43. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR and Howley PM: Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci 93: 4350-4354, 1996.
44. Li Y, Nichols MA, Shay JW and Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 bythe retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994. (Pubitemid 24378633)
45. Dysen N, Howley PM, Munger K and Harlow E: The human papilloma virus-16 E7 onco-protein is able to bind to the retinoblastoma gene product. Science 243: 934-937, 1989.
46. Boyer SN, Wazer DE and Band V: E7 protein of human papilloma virus-16 induces deg-radation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56: 4620-4624, 1996.
47. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G and Bartek J: Retinoblastoma protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503-506, 1995.
48. INK4A requires functional retinoblastoma protein. Proc Natl Acad Sci 92: 6289-6293, 1995.